Awakening and withdrawal of life-sustaining treatment in cardiac arrest survivors treated with therapeutic hypothermia

Maximilian Mulder, Haley G. Gibbs, Stephen W. Smith, Ramnik Dhaliwal, Nathaniel L. Scott, Mark D. Sprenkle, Romergryko Geocadin

Research output: Contribution to journalArticle

Abstract

Objectives: To characterize the prevalence of withdrawal of lifesustaining treatment, as well as the time to awakening, short-term neurologic outcomes, and cause of death in comatose survivors of out-of-hospital resuscitated cardiopulmonary arrests treated with therapeutic hypothermia. Design: Single center, prospective observational cohort study of consecutive patients with out-of-hospital cardiopulmonary arrests. Setting: Academic tertiary care hospital and level one trauma center in Minneapolis, MN. Patients: Adults with witnessed, nontraumatic, out-of-hospital cardiopulmonary arrests regardless of initial electrocardiographic rhythm with return of spontaneous circulation who were admitted to an ICU. Interventions: None. Measurements and Main Results: The study cohort included 154 comatose survivors of witnessed out-of-hospital cardiopulmonary arrests who were admitted to an ICU during the 54-month study period. One hundred eighteen patients (77%) were treated with therapeutic hypothermia. The mean age was 59 years, 104 (68%) were men, and 83 (54%) had an initial rhythm of ventricular tachycardia or fibrillation. Only eight of all 78 patients (10%) who died qualified as brain dead; and 81% of all patients (63 of 78) who died did so after withdrawal of life-sustaining treatment. Twenty of 56 comatose survivors (32%) treated with hypothermia who awoke (as defined by Glasgow Motor Score of 6) and had good neurologic outcomes (defined as Cerebral Performance Category 1-2) did so after 72 hours. Conclusions: Our study supports delaying prognostication and withdrawal of life-sustaining treatment to beyond 72 hours in cases treated with therapeutic hypothermia. Larger multicenter prospective studies are needed to better define the most appropriate time frame for prognostication in comatose cardiac arrest survivors treated with therapeutic hypothermia. These data are also consistent with the notion that a majority of out-ofhospital cardiopulmonary arrest survivors die after a decision to withdrawal of life-sustaining treatment and that very few of these survivors progress to brain death.

Original languageEnglish (US)
Pages (from-to)2493-2499
Number of pages7
JournalCritical Care Medicine
Volume42
Issue number12
DOIs
StatePublished - 2014

Fingerprint

Induced Hypothermia
Heart Arrest
Survivors
Coma
Brain Death
Nervous System
Cohort Studies
Therapeutics
Trauma Centers
Ventricular Fibrillation
Tertiary Healthcare
Ventricular Tachycardia
Hypothermia
Tertiary Care Centers
Multicenter Studies
Observational Studies
Cause of Death
Prospective Studies

Keywords

  • Brain death
  • Cardiac arrest
  • Outcome
  • Prognostication
  • Therapeutic hypothermia
  • Withdrawal of life-sustaining treatment

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Medicine(all)

Cite this

Awakening and withdrawal of life-sustaining treatment in cardiac arrest survivors treated with therapeutic hypothermia. / Mulder, Maximilian; Gibbs, Haley G.; Smith, Stephen W.; Dhaliwal, Ramnik; Scott, Nathaniel L.; Sprenkle, Mark D.; Geocadin, Romergryko.

In: Critical Care Medicine, Vol. 42, No. 12, 2014, p. 2493-2499.

Research output: Contribution to journalArticle

Mulder, Maximilian ; Gibbs, Haley G. ; Smith, Stephen W. ; Dhaliwal, Ramnik ; Scott, Nathaniel L. ; Sprenkle, Mark D. ; Geocadin, Romergryko. / Awakening and withdrawal of life-sustaining treatment in cardiac arrest survivors treated with therapeutic hypothermia. In: Critical Care Medicine. 2014 ; Vol. 42, No. 12. pp. 2493-2499.
@article{2252ff9408f44bef945b83227bda2588,
title = "Awakening and withdrawal of life-sustaining treatment in cardiac arrest survivors treated with therapeutic hypothermia",
abstract = "Objectives: To characterize the prevalence of withdrawal of lifesustaining treatment, as well as the time to awakening, short-term neurologic outcomes, and cause of death in comatose survivors of out-of-hospital resuscitated cardiopulmonary arrests treated with therapeutic hypothermia. Design: Single center, prospective observational cohort study of consecutive patients with out-of-hospital cardiopulmonary arrests. Setting: Academic tertiary care hospital and level one trauma center in Minneapolis, MN. Patients: Adults with witnessed, nontraumatic, out-of-hospital cardiopulmonary arrests regardless of initial electrocardiographic rhythm with return of spontaneous circulation who were admitted to an ICU. Interventions: None. Measurements and Main Results: The study cohort included 154 comatose survivors of witnessed out-of-hospital cardiopulmonary arrests who were admitted to an ICU during the 54-month study period. One hundred eighteen patients (77{\%}) were treated with therapeutic hypothermia. The mean age was 59 years, 104 (68{\%}) were men, and 83 (54{\%}) had an initial rhythm of ventricular tachycardia or fibrillation. Only eight of all 78 patients (10{\%}) who died qualified as brain dead; and 81{\%} of all patients (63 of 78) who died did so after withdrawal of life-sustaining treatment. Twenty of 56 comatose survivors (32{\%}) treated with hypothermia who awoke (as defined by Glasgow Motor Score of 6) and had good neurologic outcomes (defined as Cerebral Performance Category 1-2) did so after 72 hours. Conclusions: Our study supports delaying prognostication and withdrawal of life-sustaining treatment to beyond 72 hours in cases treated with therapeutic hypothermia. Larger multicenter prospective studies are needed to better define the most appropriate time frame for prognostication in comatose cardiac arrest survivors treated with therapeutic hypothermia. These data are also consistent with the notion that a majority of out-ofhospital cardiopulmonary arrest survivors die after a decision to withdrawal of life-sustaining treatment and that very few of these survivors progress to brain death.",
keywords = "Brain death, Cardiac arrest, Outcome, Prognostication, Therapeutic hypothermia, Withdrawal of life-sustaining treatment",
author = "Maximilian Mulder and Gibbs, {Haley G.} and Smith, {Stephen W.} and Ramnik Dhaliwal and Scott, {Nathaniel L.} and Sprenkle, {Mark D.} and Romergryko Geocadin",
year = "2014",
doi = "10.1097/CCM.0000000000000540",
language = "English (US)",
volume = "42",
pages = "2493--2499",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Awakening and withdrawal of life-sustaining treatment in cardiac arrest survivors treated with therapeutic hypothermia

AU - Mulder, Maximilian

AU - Gibbs, Haley G.

AU - Smith, Stephen W.

AU - Dhaliwal, Ramnik

AU - Scott, Nathaniel L.

AU - Sprenkle, Mark D.

AU - Geocadin, Romergryko

PY - 2014

Y1 - 2014

N2 - Objectives: To characterize the prevalence of withdrawal of lifesustaining treatment, as well as the time to awakening, short-term neurologic outcomes, and cause of death in comatose survivors of out-of-hospital resuscitated cardiopulmonary arrests treated with therapeutic hypothermia. Design: Single center, prospective observational cohort study of consecutive patients with out-of-hospital cardiopulmonary arrests. Setting: Academic tertiary care hospital and level one trauma center in Minneapolis, MN. Patients: Adults with witnessed, nontraumatic, out-of-hospital cardiopulmonary arrests regardless of initial electrocardiographic rhythm with return of spontaneous circulation who were admitted to an ICU. Interventions: None. Measurements and Main Results: The study cohort included 154 comatose survivors of witnessed out-of-hospital cardiopulmonary arrests who were admitted to an ICU during the 54-month study period. One hundred eighteen patients (77%) were treated with therapeutic hypothermia. The mean age was 59 years, 104 (68%) were men, and 83 (54%) had an initial rhythm of ventricular tachycardia or fibrillation. Only eight of all 78 patients (10%) who died qualified as brain dead; and 81% of all patients (63 of 78) who died did so after withdrawal of life-sustaining treatment. Twenty of 56 comatose survivors (32%) treated with hypothermia who awoke (as defined by Glasgow Motor Score of 6) and had good neurologic outcomes (defined as Cerebral Performance Category 1-2) did so after 72 hours. Conclusions: Our study supports delaying prognostication and withdrawal of life-sustaining treatment to beyond 72 hours in cases treated with therapeutic hypothermia. Larger multicenter prospective studies are needed to better define the most appropriate time frame for prognostication in comatose cardiac arrest survivors treated with therapeutic hypothermia. These data are also consistent with the notion that a majority of out-ofhospital cardiopulmonary arrest survivors die after a decision to withdrawal of life-sustaining treatment and that very few of these survivors progress to brain death.

AB - Objectives: To characterize the prevalence of withdrawal of lifesustaining treatment, as well as the time to awakening, short-term neurologic outcomes, and cause of death in comatose survivors of out-of-hospital resuscitated cardiopulmonary arrests treated with therapeutic hypothermia. Design: Single center, prospective observational cohort study of consecutive patients with out-of-hospital cardiopulmonary arrests. Setting: Academic tertiary care hospital and level one trauma center in Minneapolis, MN. Patients: Adults with witnessed, nontraumatic, out-of-hospital cardiopulmonary arrests regardless of initial electrocardiographic rhythm with return of spontaneous circulation who were admitted to an ICU. Interventions: None. Measurements and Main Results: The study cohort included 154 comatose survivors of witnessed out-of-hospital cardiopulmonary arrests who were admitted to an ICU during the 54-month study period. One hundred eighteen patients (77%) were treated with therapeutic hypothermia. The mean age was 59 years, 104 (68%) were men, and 83 (54%) had an initial rhythm of ventricular tachycardia or fibrillation. Only eight of all 78 patients (10%) who died qualified as brain dead; and 81% of all patients (63 of 78) who died did so after withdrawal of life-sustaining treatment. Twenty of 56 comatose survivors (32%) treated with hypothermia who awoke (as defined by Glasgow Motor Score of 6) and had good neurologic outcomes (defined as Cerebral Performance Category 1-2) did so after 72 hours. Conclusions: Our study supports delaying prognostication and withdrawal of life-sustaining treatment to beyond 72 hours in cases treated with therapeutic hypothermia. Larger multicenter prospective studies are needed to better define the most appropriate time frame for prognostication in comatose cardiac arrest survivors treated with therapeutic hypothermia. These data are also consistent with the notion that a majority of out-ofhospital cardiopulmonary arrest survivors die after a decision to withdrawal of life-sustaining treatment and that very few of these survivors progress to brain death.

KW - Brain death

KW - Cardiac arrest

KW - Outcome

KW - Prognostication

KW - Therapeutic hypothermia

KW - Withdrawal of life-sustaining treatment

UR - http://www.scopus.com/inward/record.url?scp=84922560145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922560145&partnerID=8YFLogxK

U2 - 10.1097/CCM.0000000000000540

DO - 10.1097/CCM.0000000000000540

M3 - Article

C2 - 25121961

AN - SCOPUS:84922560145

VL - 42

SP - 2493

EP - 2499

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 12

ER -